ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,543.22
1.61%
Dow Jones
40,563.06
1.39%
US Dollar vs MXN
18.66447
0.06%
Brent Oil
78.875
-1.99%
Bitcoin
58,436.36
1.56%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
16/08/202406:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:MDTMedtronic PLC
16/08/202406:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LGOLargo Inc
16/08/202406:01Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:AWXAvalon Holdngs Corp
16/08/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VBNKVersaBank
16/08/202406:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:GLTGlatfelter Corporation
16/08/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MASIMasimo Corporation
16/08/202406:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:FIXComfort Systems USA Inc
16/08/202406:00Alliance NewsAlliance NewsInspired reports "robust" first half; consideration payments to endLSE:INSEInspired Plc
16/08/202406:00GlobeNewswire Inc.Guardian Capital Announces August 2024 Cash Distributions for Guardian Capital ETFsNEO:GBFCGuardBonds 2026 Investment Grade Bond Fund
16/08/202406:00GlobeNewswire Inc.EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:EYPTEyePoint Pharmaceuticals Inc
16/08/202406:00GlobeNewswire Inc.ChampionX Declares Quarterly DividendCHX-WI
16/08/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health EmergencyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/08/202406:00GlobeNewswire Inc.Rivalry to Report Second Quarter 2024 Results on August 29, Announces Management ChangeTSXV:RVLYRivalry Corp
16/08/202406:00Business WireBowman Announces Authorization of an Increase in its Share Repurchase ProgramNASDAQ:BWMNBowman Consulting Group Ltd
16/08/202406:00GlobeNewswire Inc.Fancamp Provides Comment on Canadian Chrome Company Agreement Related to Magpie MinesTSXV:FNCFancamp Exploration Ltd
16/08/202406:00GlobeNewswire Inc.Village Farms International to Present at Investor Summit Forum on August 20 at 11:30 a.m. ETNASDAQ:VFFVillage Farms International Inc
16/08/202406:00Business WireIMFINZI® (durvalumab) approved in the US for the treatment of resectable non-small cell lung cancer before and after surgeryNASDAQ:AZNAstraZeneca PLC
16/08/202406:00Business WirePress Ganey’s PX Connect Suite Delivers Greater AI-powered Insights with Epic Workshop Integration
16/08/202406:00Business WireRedfin Reports a Record 8.5% of U.S. Homes Are Worth $1 Million or MoreNASDAQ:RDFNRedfin Corporation
16/08/202406:00GlobeNewswire Inc.AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:AIMAIM ImmunoTech Inc
16/08/202406:00Business WireAN2 Therapeutics Adopts Limited Duration Stockholder Rights PlanNASDAQ:ANTXAN2 Therapeutics Inc
16/08/202406:00Business WireGlaukos Announces Participation in Upcoming Investor ConferencesNYSE:GKOSGlaukos Corporation
16/08/202406:00Business WireNorth Beach Games Launches New Development Studio in Prague; Reveals Inaugural Survival Crafting Title, Stranded Deep 2
16/08/202406:00GlobeNewswire Inc.Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SLGLSol Gel Technologies Ltd
16/08/202406:00Business WireLaser Photonics Scores Dual Order From Global Oil Giant Through DistributorNASDAQ:LASELaser Photonics Corporation
16/08/202406:00Business WireCodaMetrix’s AI Platform Now Available in Epic Toolbox to Transform $20B Medical Coding Sector
16/08/202406:00Business WireTorus Launches 'Community' Feature to Strengthen Grid Resilience Through Microgrid Technology
16/08/202406:00Business WirenLIGHT, Inc. Announces Upcoming Investor EventsNASDAQ:LASRnLIGHT Inc
16/08/202406:00PR Newswire (Canada)Medtronic announces cash dividend for second quarter of fiscal year 2025NYSE:MDTMedtronic PLC

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
NYSE
JPM
JP Morgan Chase
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
NYSE
AXP
American Express
SPI
SP500
S&P 500
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados